HCC
EHC icon

Hirtle Callaghan & Co’s Encompass Health EHC Stock Holding History

Hirtle Callaghan & Co’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,083
Closed -$316K – 111
2022
Q2 		$316K Sell
7,083
-1,300
-16% -$66.7K 0.02% 105
2022
Q1 		$474K Buy
+8,383
New +$438K 0.02% 90

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Hirtle Callaghan & Co's EHC Position: Q3 2022 in Review

Hirtle Callaghan & Co sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 7,083 shares — an estimated $316K sold.

Hirtle Callaghan & Co first reported a position in EHC in Q1 2022 and held it in 2 quarters. The position peaked at $474K in Q1 2022. 346 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • Hirtle Callaghan & Co reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 7,083 Encompass Health shares in Q3 2022, an estimated $316K.
  • Hirtle Callaghan & Co first reported a position in Encompass Health in Q1 2022 and held it in 2 quarters.
  • Hirtle Callaghan & Co's Encompass Health position peaked at $474K in Q1 2022.
  • 346 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2022, filed 14 Nov 2022.